Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Industrial Goods Companies: MSC Industrial (MSM) and Fortune Brands Innovations (FBIN)

Tipranks - Sun Apr 5, 7:14AM CDT

Analysts fell to the sidelines weighing in on MSC Industrial (MSM) and Fortune Brands Innovations (FBIN) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.

Easter Sale - 70% Off TipRanks

MSC Industrial (MSM)

In a report released yesterday, Patrick Baumann from J.P. Morgan maintained a Hold rating on MSC Industrial, with a price target of $97.00. The company’s shares closed last Thursday at $90.32.

Baumann has an average return of 15.9% when recommending MSC Industrial. ;'>

According to TipRanks.com, Baumann is ranked #4422 out of 12128 analysts.

Currently, the analyst consensus on MSC Industrial is a Hold with an average price target of $92.60, representing a 0.6% upside. In a report issued on March 20, TipRanks – Google also downgraded the stock to Hold with a $91.00 price target.

See today’s best-performing stocks on TipRanks >>

Fortune Brands Innovations (FBIN)

In a report released yesterday, Michael Rehaut from J.P. Morgan maintained a Hold rating on Fortune Brands Innovations, with a price target of $42.00. The company’s shares closed last Thursday at $37.24.

According to TipRanks.com, Rehaut is a 4-star analyst with an average return of 5.9% and a 55.3% success rate. Rehaut covers the NA sector, focusing on stocks such as Installed Building Products, Taylor Morrison, and Toll Brothers. ;'>

Fortune Brands Innovations has an analyst consensus of Hold, with a price target consensus of $56.29, a 51.7% upside from current levels. In a report issued on March 30, Truist Financial also maintained a Hold rating on the stock.

Read More on MSM:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.